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The solution structure of human thioredoxin complexed with its
target from Ref-1 reveals peptide chain reversal
Jun Qin, G Marius Clore*, W Poindexter Kennedy, John Kuszewski 
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Background:  Human thioredoxin (hTRX) is a 12 kDa cellular redox protein that
has been shown to play an important role in the activation of a number of
transcriptional and translational regulators via a thiol-redox mechanism. This activity
may be direct or indirect via another redox protein known as Ref-1. The structure
of a complex of hTRX with a peptide comprising its target from the transcription
factor NFkB has previously been solved. To further extend our knowledge of the
recognition by and interaction of hTRX with its various targets, we have studied a
complex between hTRX and a Ref-1 peptide. This complex represents a kinetically
stable mixed disulfide intermediate along the reaction pathway.
Results:  Using multidimensional heteronuclear edited and filtered NMR
spectroscopy, we have solved the solution structure of a complex between hTRX
and a 13-residue peptide comprising residues 59–71 of Ref-1. The Ref-1
peptide is located in a crescent-shaped groove on the surface of hTRX, the
groove being formed by residues in the active-site loop (residues 32–36), helix
3, b strands 3 and 5, and the loop between b strands 3 and 4. The complex is
stabilized by numerous hydrogen-bonding and hydrophobic interactions that
involve residues 61–69 of the peptide and confer substrate specificity.
Conclusions:  The orientation of the Ref-1 peptide in the hTRX–Ref-1 complex
is opposite to that found in the previously solved complex of hTRX with the
target peptide from the transcription factor NFkB. Orientation is determined by
three discriminating interactions involving the nature of the residues at the P–2,
P–4 and P–5 binding positions. (P0 defines the active cysteine of the peptide,
Cys65 for Ref-1 and Cys62 for NFkB. Positive and negative numbers indicate
residues N-terminal and C-terminal to this residue, respectively, and vice versa
for NFkB as it binds in the opposite orientation.) The environment surrounding
the reactive Cys32 of hTRX, as well as the packing of the P+3 to P–4 residues
are essentially the same in the two complexes, despite the opposing orientation
of the peptide chains. This versatility in substrate recognition permits hTRX to
act as a wide-ranging redox regulator for the cell.
Introduction
Thioredoxin is an oxido-reductase [1,2] that has been
shown to play a key role in the activation of a number of
transcriptional [3–10] and translational [11–12] regulators.
It operates via a thiol-redox mechanism involving the
reduction of specific cysteine residues of the substrate.
This activity may be direct, as in the case of NFkB [3–5]
and the psbA mRNA protein complex [11,12], or indirect
via another redox protein known as Ref-1 [8,9]. The solu-
tion structure of human thioredoxin (hTRX) in an inter-
molecular (otherwise known as mixed) disulfide complex
with a peptide comprising its target site from the tran-
scription factor NFkB showed that the complex is stabi-
lized by numerous interactions that confer substrate
specificity [12]. We now present the solution structure of
hTRX in a complex with a peptide comprising its target
site from Ref-1, and show that the binding orientation of
the Ref-1 peptide is opposite to that of the NFkB peptide.
Thus, hTRX illustrates novel principles of flexible sub-
strate recognition that permit disulfide-bond reduction of
a wide variety of target proteins.
Redox control of the DNA-binding activity of the tran-
scription factor AP-1 (a heterodimer of fos and jun) by
Ref-1 is stimulated by the thioredoxin/thioredoxin reduc-
tase system [8,9]. The region essential for Ref-1 redox
activity has been localized to the N terminus of the
protein, and site-directed mutagenesis has identified the
cysteine at position 65 as the redox active site [13,14].
Upon oxidation, Ref-1 becomes redox inactive and is no
longer able to activate AP-1. The activity of Ref-1 is
restored by hTRX [8,9,13,14]. Indeed, a direct physical
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and functional interaction between Ref-1 and human thio-
redoxin has been demonstrated both in vivo and in vitro
using the yeast two hybrid system, cross-linking, and
surface plasmon resonance (J Yodoi, personal communica-
tion). We have investigated this interaction at the atomic
level by solving the three-dimensional (3D) structure of a
complex of human thioredoxin with a peptide comprising
the relevant target site from Ref-1.
Results and discussion
Structure determination
The mixed disulfide intermediate was formed by reacting
the quadruple (Cys35→Ala, Cys62→Ala, Cys69→Ala and
Cys73→Ala) mutant of hTRX with a 13-residue peptide
comprising residues 59–71 of Ref-1 and purifying the
resulting complex by HPLC. The Cys62→Ala, Cys69→Ala
and Cys73→Ala mutations prevent any problems associ-
ated with the formation, upon oxidation, of intermolecular
disulfide bonds upon oxidation involving the three non-
active-site cysteine residues [15]. The Cys35→Ala muta-
tion ensures that the reaction does not proceed beyond the
mixed disulfide intermediate (Cys35 acts as the resolving
sulfhydryl anion in the native complex) [12]. The intermol-
ecular disulfide bond is formed between the two reactive
cysteines, Cys32 of hTRX [1] and Cys65 of Ref-1 [13]. The
solution structure was solved by multidimensional het-
eronuclear-edited and -filtered NMR spectroscopy making
use of isotopically labelled hTRX (15N and 15N/13C) and
the Ref-1 peptide at natural isotopic abundance [16–18].
The structure determination was based on a total of 3663
experimental NMR restraints, including 55 intermolecular
interproton distance restraints. An example of the quality 
of the experimental data is shown in Figure 1. This illus-
trates strips taken from the 3D 13C-edited(F2)/12C(F3)-fil-
tered nuclear Overhauser enhancement (NOE) spectrum,
showing intermolecular contacts between 13C-attached
protons of hTRX and 12C-attached protons of the unla-
beled Ref-1 peptide. A summary of the structural statistics
is provided in Table 1, and a superposition of the final 35
structures is shown in Figure 2. The structure is well
defined with a precision (excluding residues 59–60 and
70–71 of the peptide which are disordered and do not inter-
act with hTRX) of 0.24±0.02 Å for the backbone atoms,
0.29±0.34 Å for all ordered atoms and 0.50±0.03 Å for all
atoms (Table 2). 92% of the residues lie in the most
favoured regions of the Ramachandran plot, and the
remaining 8% are in the additional allowed regions [19].
The backbone rms difference for the protein between its
mean coordinates in the hTRX–Ref-1 complex and those
in the hTRX–NFkB complex [12], oxidized hTRX and
reduced hTRX [15], are 0.62, 0.72 and 0.75 Å, respectively.
Description of the complex
A detailed view of the interactions between the peptide
and hTRX is shown in Figure 3. To facilitate discussion
we denote the residue numbering of the Ref-1 peptide as
follows: P0 represents the disulfide-bonded cysteine, and
positive and negative numbers indicate residues N-termi-
nal and C-terminal to this cysteine, respectively. (Note
that in the complex with the NFkB peptide [12], positive
and negative numbers indicate residues C-terminal and
N-terminal to the disulfide-bonded cysteine, respectively,
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Figure 1
Composite of 13C-1H strips taken from the
120 ms mixing time 600 MHz 3D 13C(F2)-
edited/12C(F3)-filtered NOE spectrum of the
hTRX–Ref-1 peptide complex, illustrating
NOEs between protons of the unlabeled
peptide (attached to 12C along the F3 axis)
and protons of labeled hTRX (attached to
13C). Residues of hTRX and the Ref-1 peptide
are indicated by upper-case and lower-case
letters, respectively.
as the NFkB peptide binds in the opposite orientation to
the Ref-1 peptide; see below. The disulfide-bonded cys-
teine [P0] for NFkB is Cys62.) The structure of hTRX
consists of a five-stranded b sheet (residues 1–5, 22–28,
53–59, 75–81 and 84–91) surrounded by four a helices
(residues 7–17, 33–49, 62–70 and 94–105). The active site
comprises a protrusion (residues 32–36) on the surface of
the protein. The peptide binds in a crescent-shaped
groove formed by residues in the active site, at the C ter-
minus of strand b3, in helix 3, in the loop between helix 3
and strand b4, and in strand b5. The overall conformation
of the bound peptide is essentially extended and follows
the shape of the cleft. At the N terminus of the peptide
there is a helical turn from residues 61 to 64 with a hydro-
gen bond between thr61 O (the P+4 position) and ile64 N
(P+1) as the peptide abuts the upper most point of the cleft.
(Note that residues of hTRX and the peptide are distin-
guished by the first letter of the three-letter code, which is
denoted by a capital and a small letter, respectively). In
addition, there is another distorted helical turn from
residues 66 to 69 with a hydrogen bond between ser66 O
(P–1) and val69 N (P–4). This turn serves to orient val69
such that it can interact with the aromatic ring of Trp31. 
The most remarkable feature of the complex is that the
orientation of the Ref-1 peptide is opposite to that found
in the complex with the target peptide from NFkB,
although many of the interactions are preserved, as illus-
trated in Figures 4 and 5. Thus, the Ref-1 peptide is ori-
ented antiparallel whereas the NFkB peptide is oriented
parallel to residues 74–76 of hTRX. In both complexes,
there are three intermolecular backbone–backbone hydro-
gen bonds involving Ala92 N, Thr74 O and Thr74 N of
hTRX. Thus, the two intermolecular backbone–backbone
hydrogen bonds involving Thr74 define the orientation 
of the peptide. In the case of Ref-1, these residues are
hydrogen bonded to lys63 O (P+2), cys65 N (P0) and
cys65 O (P0), respectively; for NFkB they are hydrogen
bonded to glu63 O (P+1), glu63 N (P+1) and val61 O (P–1).
It should be noted that the positions and orientations of
cys65 NH (P0) and cys65 O (P0) in the Ref-1 peptide are
essentially superimposable on those of glu63 N (P+1) and
val61 O (P–1), respectively, in the NFkB peptide. In both
cases, there is also an intermolecular hydrogen bond
between the hydroxyl group of Thr74 of hTRX and the
sulfur atom of the P0 cysteine residue of the peptide. The
majority of hydrophobic interactions are also preserved.
Thus, the P+3 residue interacts with Pro34; the P+2 residue
with Pro34 and Ala92; the P+1 residue with Ser90 and
Gly91; the P0 residue with Trp31, Pro34 and Ala35; the
P–1 residue with Ala73; the P–2 residue with Val59, Val71,
Lys72, Ala73 and Lys74; and the P–4 residue with Trp31.
There are no cavities or unsatisfied hydrogen-bonding
groups at the hTRX–peptide interface in either complex.
It is worth noting that the variant of hTRX employed in
this study has a threonine at position 74 [20], whereas
another variant has a methionine at this position [21]. This
difference should have little effect on the hydrophobic
interaction between the residue at position 74 and the aro-
matic ring at the P–2 position (tryptophan in the case of
Ref-1 and tyrosine for NFkB) [12].
The importance of hydrophobic interactions in stabilizing
the formation of these complexes can be ascertained by
calculating the solvation free energy (SFE) of folding [22].
Formation of the hTRX–Ref-1 complex is associated with
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Table 1
Structural statistics.*
Structural statistics <SA> (SA
__
)r
Rms deviations from exptl distance restraints (Å)†
All (2617) 0.036±0.035 0.035
Intramolecular hTRX interproton distances
interresidue sequential (|i–j|=1) (534) 0.030±0.002 0.029
interresidue short range (1<|i–j|≤5) (539) 0.048±0.002 0.047
interresidue long range ((|i–j|)>5) (688) 0.036±0.002 0.034
intraresidue (682) 0.016±0.002 0.018
Intramolecular Ref-1 peptide 
interproton distances (83) 0.036±0.006 0.034
Intermolecular hTRX-Ref1
interproton distances (55) 0.062±0.004 0.059
hTRX hydrogen-bond restraints (36) 0.072±0.072 0.055
Rms deviations from 3JHNa
coupling constants (Hz) (86)† 0.79±0.02 0.79
Rms deviations from 
exptl dihedral restraints (°) (321)†,‡ 0.35±0.05 0.37
Rms deviations from exptl secondary shifts (ppm)
13Ca (100) 1.08±0.02 1.07
13Cb (97) 1.07±0.01 1.08
Rms deviations from exptl 1H shifts (442)‡ 0.27±0.002 0.28
Deviations from idealized covalent geometry
Bonds (Å) (1835) 0.004±0.0001 0.006
Angles (°) (3333) 0.570±0.010 0.684
Impropers (°) (938)§ 0.476±0.013 0.524
EL-J (kcal mol–1)# –568±7 –548
*The notation of the NMR structures is as follows: <SA> is the ensemble
comprising the final 35 simulated annealing structures; SA
__
is the mean
structure obtained by averaging the coordinates of the individual SA
structures best fitted to each other (excluding residues 59–60 and
70–71 of the Ref-1 peptide); (SA
__
)r is the restrained regularized mean
structure obtained by restrained regularization of the mean structure SA
__
[37]. The number of terms for the various restraints are given in
parentheses and apply to the entire complex. †None of the structures
exhibit distance violations greater than 0.3 Å, dihedral angle violations
greater than 5°, or 3JHNa coupling constant violations greater than 2 Hz;
there are no systematic interproton distance violations between 0.1 and
0.3 Å among the ensemble of calculated structures. ‡The dihedral angle
restraints comprise 104 f, 76 c, 78 x1 and 30 x2 angles for hTRX, and
11 f, 9 c, 9 x1 and 4 x2 angles for the Ref-1 peptide. The 1H chemical
shifts comprise 113 CaH protons, 67 methyl groups and 262 other non-
exchangeable protons. §The improper torsion restraints serve to maintain
planarity and chirality. All peptide bonds were constrained to be planar
and trans with the exception of the peptide bond between Thr74 and
Pro75 which is in the cis conformation. #EL-J is the Lennard-Jones van
der Waals energy calculated with the CHARMM [43] empirical energy
function and is not included in the target function for simulated annealing
or restrained minimization.
a decrease of 624 Å2 and 324 Å2 in the solvent accessible
surface area of the Ref-1 peptide and hTRX, respectively.
This corresponds to an overall decrease in the calculated
SFE of ~13 kcal mol–1. Somewhat more accessible surface
area is buried in the case of the hTRX–NFkB complex
(768 Å2 and 535 Å2 for the peptide and protein, respec-
tively), but the overall decrease (~12.5 kcal mol–1) in the
calculated SFE is essentially unchanged. Thus, both com-
plexes should be very stable even in the absence of the
formation of an intermolecular disulfide bridge.
Determinants of substrate orientation
How does hTRX recognize substrates in opposing orienta-
tions? We suggest that there are three discriminating inter-
actions (all shown in Fig. 5). The first, and possibly the
most important, discriminant is the presence of an aromatic
residue at the P–2 position (trp in the case of Ref-1 and tyr
for NFkB). Upon complex formation, this residue becomes
buried in a deep hydrophobic pocket. It is also possible for
a long-chain hydrophobic such as ile or leu to occupy this
position. The second is the presence of a hydrophobic
residue at the P–4 position, which interacts with the aro-
matic ring of Trp31. Finally, the third is the nature of the
P–5 residue. In the case of the NFkB the residue at P–5 is a
positively charged arginine permitting additional electro-
static interactions, in the form of two salt bridges with the
side-chain carboxylates of Asp58 and Asp61. For the Ref-1
peptide, on the other hand, the P–5 residue is negatively
charged and precludes electrostatic interactions with
hTRX beyond the P–4 position. Thus, substrate side-chain
interactions with hTRX determine the orientation of the
peptide. The few main-chain interactions between hTRX
and the two peptide substrates are centered around the
intermolecular disulfide bond and do not have long-range
asymmetry to discriminate between peptide orientations.
In considering the interaction of hTRX with target proteins,
it is natural to ask oneself whether it is reasonable to expect
the major determinants of binding to be located along a
single peptide chain. Although it is clearly possible that con-
tacts with other portions of the target proteins may occur,
the results presented in this paper, as well as in the previous
paper on the complex of hTRX with the NFkB peptide
[12], strongly suggest that the major determinants are
indeed located along a single peptide chain centered around
the reactive cysteine of the target. Specifically, the similari-
ties in the sequence dependence of certain key binding
residues in the hTRX–Ref-1 and hTRX–NFkB peptide
complexes support the assumption that these peptide
model systems are actually representative of the real situa-
tion in the entire complex. This is further substantiated by
the observation that in the X-ray structure of Anabena
thioredoxin-2 binding occurs in the same orientation and
location as for the NFkB peptide: the N-terminal residues
of one molecule bind in the active-site region, parallel to
residues 74–76 of another molecule [23]. Despite these
structural arguments, it should be noted that no competi-
tion binding data are available which directly demonstrate
that the Ref-1 peptide competes with full-length Ref-1. 
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Figure 2
Stereoview showing a best fit superposition of
the backbone (N, Ca, C) atoms and ordered
side chains of the 35 simulated annealing
structures of the hTRX–Ref-1 complex. The
backbone and side chains of hTRX are shown
in red and blue, respectively; the backbone
and side chains of the Ref-1 peptide are
shown in green and magenta, respectively;
and the disulfide bond between Cys32 of
hTRX and cys65 of the Ref-1 peptide is
shown in yellow. Residues of hTRX and Ref-1
are distinguished by upper- and lower-case
letters, respectively.
Table 2
Atomic rms differences (Å).*
Backbone All All ordered
atoms atoms atoms†
<SA> versus SA
__
0.24±0.02 0.50±0.03 0.29±0.03
<SA> versus (SA
__
)r 0.25±0.06 0.56±0.04 0.33±0.04
(SA
__
)r versus SA
__
0.067 0.27 0.15
*The notation of the structures is given in Table 1 footnote. †The
coordinate precision is defined as the average atomic rms difference
between the individual simulated annealing structures and the mean
coordinates SA
__
. The values reported relate to residues 1–105 of hTRX
and residues 61–69 of the Ref-1 peptide. The atoms that do not
exhibit conformational disorder comprise all N, Ca, C, O and Cb atoms
of residues 1–105 of hTRX and 61–69 of the Ref-1 peptide; the
complete hTRX side chains of residues 2, 5, 7–9, 10, 11, 14, 15, 17
to 19, 22–25, 27, 29–35, 38, 40–43, 45, 46, 49–55, 57, 59, 60, 62,
65–67, 69, 71, 73–80, 83, 86–92, 97 and 99–105; the complete
side chains of the Ref-1 peptide excluding those of residues 59–60
and 70–71; and the hTRX side chains of Met1, Gln12, Ser28, Met37,
Ser44 and Glu88 up to Cb, Lys3, Glu6, Glu13, Asp16, Asp20,
Asp26, Glu47, Asp58, Asp61, Asp64, Lys72, Gln84, Asn93, Lys94,
Glu95 and Glu98 up to Cg, and Gln4, Lys8, Lys21, Lys36, Lys39,
Lys48, Glu56, Glu68, Glu70, Lys81, Lys85 and Lys96 up to Cd.
Antiparallel binding (i.e. in the same orientation as the
Ref-1 peptide in the hTRX–Ref-1 complex) has been
observed for the glutathione peptide in glutathione-
binding proteins [24,25], and it has been proposed that a
cis-proline (corresponding to residue 75 in hTRX) plays a
major role in positioning the substrate for the thiol
exchange reaction [26]. Indeed, examination of the posi-
tion of the cis Pro75 ring in the structures of both the Ref-
1 and NFkB peptide complexes reveals a strikingly similar
arrangement for this side chain relative to the disulfide
bond. The ring of Pro75 abuts, from one side, the sulfur of
the P0 cysteine in the bridge, presumably assuring the
correct positioning of the sulfur of Cys32 for nucleophilic
attack by the resolving sulfhydryl anion, Cys35 (which is
replaced by alanine in the complex described here). 
The complexes of hTRX with target peptides from Ref-1
and NFkB represent only the second example of a protein
recognizing peptides in distinct orientations. The other
example is that of the recognition of polyproline-contain-
ing peptides by SH3 domains, in which the orientation is
determined by the nature of the residues at the P0 and P–3
positions [27–29]. However, in contrast to the SH3
domain, hTRX does not simply bind the target peptides
but also carries out a chemical reaction. This involves
nucleophilic attack by the highly reactive Cys32 thiolate
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Figure 3
Stereoview showing the interactions between
the Ref-1 peptide and hTRX. The backbones
(N, Ca, C) of hTRX and the Ref-1 peptide are
shown in blue and red, respectively; the side
chains of hTRX and the Ref-1 peptide at the
interface of the complex are shown in
magenta and green, respectively; and the
disulfide bond between Cys32 of hTRX and
cys62 of the Ref-1 peptide is shown in yellow.
(The figure was generated with the program
VISP [44].)
Figure 4
Comparison of (a) the hTRX–Ref-1 and
(b) hTRX–NFkB peptide complexes. hTRX is
represented as a molecular surface illustrating
the cleft in which the two peptides, in their
opposing orientations, are located. The
degree of curvature of the molecular surface
is color coded from white (convex) to dark
grey (concave), and the N- and C-terminal
ends of the two peptides are indicated in red
lettering. The backbone of the peptides is
shown in green, and side chains are colored
as follows: cysteine, isoleucine, leucine,
phenylalanine, proline, tyrosine and valine,
yellow; arginine, blue; aspartate and
glutamate, red; and asparagine, serine and
threonine, magenta. (The figure was
generated with the program GRASP [45].)
anion of the reduced species of hTRX on a disulfide-con-
taining substrate, producing a mixed disulfide intermedi-
ate. Attack by the thiolate of Cys35 then follows, yielding
a reduced substrate and oxidized hTRX. Consequently,
the environment surrounding the reactive Cys32 has to be
nearly identical in the two complexes; the packing of the
P+3 to P–4 residues are essentially the same in the
hTRX–Ref-1 and hTRX–NFkB complexes, despite the
opposing orientations of the peptide chain. Such strin-
gency is not necessary in the SH3 case where the residues
at the P–1, P0, P2 and P3 sites pack in different ways
depending upon the orientation of the peptide (internal,
external, internal, external, respectively for one orienta-
tion; external, internal, external, internal, respectively, for
the other orientation [27]). 
To summarize, hTRX (as well as thioredoxins from other
species) is distinct from most enzymes whose active site
is located in a deep cleft. In hTRX, the active site is
located on a protrusion of the molecular surface. The
peptide substrates in the hTRX–Ref-1 and hTRX–NFkB
complexes are wrapped around the protrusion of the reac-
tive Cys32 in a crescent-shaped groove created by the
backbone fold and side chains of hTRX. As a redox regu-
lator for the cell, hTRX appears to have balanced versatil-
ity in substrate specificity with the requirements for
access to substrates (some of which are known to be par-
tially buried, such as the intersubunit disulfide of the
NFkB p50 homodimer [30,31]).
Biological implications
The activation of a growing number of transcriptional
and translational regulators has been shown to involve a
thiol-redox control mechanism whereby specific cysteine
residues are reduced by a cellular redox protein [3–11].
Human thioredoxin (hTRX) has been shown to play a
key role in this process; it either interacts directly with
these regulators, as in the case of the transcriptional
factor NFkB and the translational regulator psbA
mRNA protein complex, or via an indirect mechanism
involving the intermediate redox protein Ref-1, as in the
case of the transcriptional factor AP-1. An understand-
ing of the molecular basis of this phenomenon requires
the structure determination of cellular redox proteins in
complexes with their targets [12].
We have previously solved the structure of a mixed
(intermolecular) disulfide intermediate complex of
hTRX and a 13-residue peptide comprising the target site
of the p50 subunit of NFkB (residues 56–68). The
complex is stabilized by numerous hydrogen-bonding,
electrostatic and hydrophobic interactions, similar to
those found in other high affinity protein–peptide com-
plexes [12]. We have now determined the structure of a
mixed disulfide intermediate complex of hTRX and a 13-
residue peptide comprising the target site of Ref-1
(residues 59–71). Although the Ref-1 peptide is found in
the same location as the NFkB peptide, that is, a cres-
cent-shaped groove on the surface of hTRX, the surpris-
ing finding is that the orientation of the Ref-1 peptide is
opposite to that of the NFkB peptide. (To facilitate dis-
cussion the residue numbering of the two peptides is
denoted as follows: P0 represents the disulfide-bonded
cysteine; positive and negative numbers indicate residues
N- and C-terminal to this cysteine, respectively, in the
case of Ref-1, and C- and N-terminal to this cysteine,
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Figure 5
Schematic summary of the interactions observed in the hTRX–Ref-1
and hTRX–NFkB complexes. (a) All interactions with the exception of
those involving backbone–backbone hydrogen bonds: hydrophobic,
hydrogen-bonding and salt bridge interactions are represented by
continuous (———), long dashed (–––) and short dashed (---) lines,
respectively. (b) Backbone–backbone hydrogen bonds.
respectively, in the case of NFkB as it binds in the oppo-
site orientation to the Ref-1 peptide). Despite the differ-
ences in orientation, the environment surrounding the
reactive Cys32 (which is responsible in the reduced
species for nucleophilic attack on a disulfide-containing
substrate, yielding a mixed disulfide intermediate) of
hTRX, as well as the packing of the residues in the P–4 to
P+3 positions, is very similar in the two complexes. Three
discriminating interactions determine the orientation of
the bound peptides: the presence of an aromatic (or pos-
sible long chain hydrophobic) residue at the P–2 position
which is buried in a deep hydrophobic pocket; the pres-
ence of an aliphatic residue at the P–4 position to inter-
act with the aromatic ring of Trp31 of hTRX; and the
presence or absence of a positively charged residue at the 
P–5 position, to interact with the side-chain carboxylates 
of Asp58 and Asp61 of hTRX. The ability of hTRX to
recognize peptides in opposing orientations indicates that
this redox protein has succeeded in balancing versatility
in substrate recognition with the requirements for access
to substrates. Thereby, hTRX has the potential to target
a wide range of proteins within the cell.
Materials and methods
Sample preparation
Uniformly labeled (>95%) 15N and 15N/13C (Cys35→Ala, Cys62→Ala,
Cys69→Ala and Cys73→Ala) quadruple mutant of hTRX was
expressed and purified as described previously, using 15NH4Cl and
13C6-glucose as the sole nitrogen and carbon sources, respectively
[12,15]. The Ref-1 peptide P59ATLKICSWNVDG71 was synthesized
using solid-phase methods and purified by HPLC using a C4-reversed
phase column. Purity of the peptide was checked by mass spectrome-
try and NMR spectroscopy. The mixed disulfide intermediate complex
between hTRX and the Ref-1 peptide was formed and purified exactly
as described previously for the complex between hTRX and the NFkB
peptide [12]. The purified complex was taken up in either 99.996%
D2O or 90% H2O/10% D2O. 
NMR spectroscopy
All NMR experiments were carried out at 25°C on either a Bruker
AMX600 or AMX500 spectrometer equipped with a z-shielded gradient
triple resonance probe. The NMR spectra were processed with the
NmrPipe package [32] and analysed using the programs PIPP, CAPP
and STAPP [33]. Sequential assignment of the 1H, 13C and 15N reso-
nances, stereospecific assignments of b-methylene protons and methyls
of leucine and valine, and the measurement of three-bond homonuclear
and heteronuclear J couplings (3JHNa, 3Jab, 3JNHb, 3JCOHb, 3JCgN, 3JCgCO,
3JCC) were achieved using the same set of 2D and 3D hetero-
nuclear experiments described previously [12]. The 1H resonances of 
the Ref-1 peptide were assigned using the conventional sequential 
assignment procedure using 2D 12C(F1,F2)-filtered HOHAHA and 
12C(F1,F2)-filtered NOE spectra in D2O, and 14N/12C(F1,F2)-filtered 
NOE and 14N(F2)-filtered COSY spectra in H2O. Approximate inter-
proton distance restraints were derived from the following NOE 
spectra recorded with a mixing time of 120 ms: 2D 12C(F1,F2)-filtered, 
12C/14N(F1,F2)-filtered and 14N(F2)-filtered NOE spectra; 3D 15N-edited,
13C-edited and 13C-edited(F2)/12C-filtered(F3) NOE spectra; and 4D
15N/13C-edited, 13C/13C-edited NOE spectra. Details of all the NMR
experiments employed, together with original references, are provided in
[16–18,34]. The interproton distance restraints were grouped into four
ranges: 1.8–2.7 Å (1.8–2.9 Å for NOEs involving NH protons), 
1.8–3.3 Å (1.8–3.5 Å for NOEs involving NH protons), 1.8–5.0 Å, and 
1.8–6.0 Å, corresponding to strong, medium, weak and very weak NOEs,
respectively. In addition, 0.5 Å was added to the upper limit of distances
involving methyl protons to account for the higher apparent intensity of
methyl resonances. Non-stereospecifically assigned methylene protons
and methyl groups were treated as a (Sr–6)–1/6 sum [35]. Stereospecific
assignments and f, c and x1 torsion angle restraints were obtained
using the conformational grid search program STEREOSEARCH on the
basis of the 3JHNa and 3Jab coupling constants and intraresidue and
sequential interresidue interproton distance restraints involving the NH,
CaH and CbH protons [36]. Information from 3JNHb and 3JCOHb cou-
pling constants was also employed for identifying the appropriate x1
rotamer and for detecting rotamer averaging. x1 torsion angles for valine
and threonine residues and stereospecific assignments for the methyl
groups of valine residues were obtained from 3JCgN and 3JCgCO coupling
constants, in conjunction with the pattern of intraresidue NOEs. x2
torsion angle restraints for isoleucine and leucine residues and stereo-
specific assignments for the methyl groups of leucine were obtained
from 3JCC coupling constants and the pattern of intraresidue NOEs.
Stereospecific assignments were obtained for 52 out of the 69 b-meth-
ylene groups, all methyl groups of the 6 leucine and 10 out of 11 valine
residues of hTRX, 7 out of 8 b-methylene groups and the methyl groups
of the single leucine residue of the Ref-1 peptide. 
Structure calculations
The structures were calculated using the hybrid distance geometry-
simulated annealing protocol [37] which makes use of the program
XPLOR-31 [38]. The target function that is minimized during simulated
annealing (SA) comprises quadratic harmonic potential terms for cova-
lent geometry (that is bonds, angles, planes and chirality), square-well
quadratic potentials for the experimental distance and torsion angle
restraints, harmonic potentials for the 3JHNa coupling constant [39],
13Ca and 13Cb secondary chemical shift [40] and 1H chemical shift
[41] restraints, and a quartic van der Waals repulsion term for the non-
bonded contacts. In addition, a conformational database potential term
[42] was included to restrict sampling during simulated annealing
refinement to conformations that are likely to be energetically possible,
thereby limiting the choices of dihedral angles to those that are known
to be physically realizable; in this manner the variability in the structures
is primarily the result of the experimental restraints, rather than an arti-
fact of a poor non-bonded interaction model [42]. No hydrogen-
bonding, electrostatic or 6–12 Lennard-Jones empirical potential
energy terms are present in the target function. The 3JHNa coupling
constants included directly in the refinement comprised only those that
could be measured from the 3D HNHA experiment to an accuracy of
0.5 Hz or better. The minimum ranges employed for the f, c, x1 and x2
torsion angle restraints were ±10°, ±50°, ±20° and ±20°, respectively.
The narrow range for some of the f restraints was made possible by
the availability of highly accurate 3JHNa coupling constant data. The x2
angles of all tyrosine and phenylalanine aromatic rings were restrained
to 90±30°. In all cases the angular standard deviations of the torsion
angles for the ensemble of 35 final SA structures were much smaller
than the ranges employed for the corresponding torsion angle
restraints. Only structurally useful intraresidue NOEs were included in
the intraresidue interproton distance restraints. Thus, NOEs between
protons separated by two bonds or between non-stereospecifically
assigned protons separated by three bonds were not incorporated in
the restraints. Hydrogen bonding restraints, which account for all the
slowly exchanging backbone amide protons, were only included in the
final stages of refinement. For each backbone hydrogen bond there are
two distance restraints: rNH-O, 1.7–2.5 Å; rN-O, 2.3–3.5 Å. (Note that
these distance criteria were also used to assess the presence of inter-
molecular hydrogen bonds between hTRX and the Ref-1 peptide).
Accession numbers
The coordinates of the 35 final simulated annealing (SA) structures of the
hTRX–Ref-1 complex, together with the coordinates of the restrained
regularized mean structure, (SA
__
)r, and the experimental restraints have
been deposited in the Brookhaven Protein Databank (accession number
1CQG). The coordinates can also be obtained by e-mail from GMC at
clore@vger.niddk.nih.gov.
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